-
A semisynthetic derivative of sirolimus (rapamycin)
Temsirolimus Source
-
Macrolide (macrocyclic lactone) skeleton
Rapamycin derivative: 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate] rapamycin
Colorless solid
No ionizable functional groups
Water insoluble
Temsirolimus Chemistry
-
An inhibitor of the enzyme mTOR (mammalian Target Of Rapamycin – a keyregulatory kinase)
Binds to an intracellular protein (FKBP-12)
This protein-drug complex inhibits the activity of mTOR that controls cell division
Inhibition of mTOR activity resulted in a G1growth arrest in treated tumor cells
Temsirolimus, Everolimus, and Ridaforolimus MOA
-
Renal Cell Carcinoma
Temsirolimus Common Application
-
Hyperlipidemia and hyperglycemia
Temsirolimus Special AEs
-
Macrolide (macrocyclic lactone) skeleton
A semi-synthetic derivative of Rapamycin (Sirolimus): 42-O-(2-hydroxy)ethyl rapamycin
Colorless solid
No ionizable functional groups
Water insoluble
Everolimus Chemistry
-
Renal Cell Carcinoma
Pancreatic Neuroendocrine Tumors (unresectable, locally advanced or metastatic disease)
subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosisin patients who require therapy but are not candidates for surgical resection
Everolimus Common Applications
-
These two drugs do not have any special adverse effects detailed
Everolimus & Ridaforolimus (Special AEs)
-
Macrolide (macrocyclic lactone) skeleton
A semi-synthetic derivative of Rapamycin (Sirolimus): 42-O-dimethylphosphinate rapamycin
Colorless solid
No ionizable functional groups
Water insoluble
Ridaforolimus Chemistry
-
In Phase 3 clinical trials for the therapy ofmetastatic soft-tissue and bone sarcomas that are responsive to chemotherapy
In Phase 2 clinical trials ongoing for advanced endometrial cancer, prostate cancer and non-small cell lung cancer
Ridaforolimus Common Applications
-
A semisynthetic derivative of thepolyketide macrolactone (macrolide)Epothilone B
The first of the epothilones, a new class ofcytotoxic compounds
Ixabepilone Source
-
macrolactam derivative of the macrolactone Epothilone B
No readily ionizable functional groups; Lactam N atom is neutral; Thiazole N atom electrons are delocalized in ring current and unavailable for salt formation
Solubility is achieved via incorporation into solution in a mixture of Polyoxyethylated castor oil (52.8%) & Dehydrated alcohol (39.8%)
Ixabepilone Chemistry
-
MOA similar to the taxanes: Bind directly to the αβ-tubulin heterodimersubunit on microtubules. Once bound, the rate of heterodimeric tubulin dissociation decreases ->-> stabilizes the microtubules ->-> inhibits microtubule depolymerization
Acts as an antimitotic - blocks the metaphase -> anaphase step in mitosis which leads to apoptosis
Binds in a unique manner to β-tubulin and appears to be active against taxane-resistant tumor cell lines
Ixabepilone MOA
-
Combination with Capecitabine (Xeloda®) in the therapy of metastatic or locally advanced breast cancer patients after failure of an anthracycline and a taxane
Monotherapy of metastatic or locally advanced breast cancer in patients after failure of an anthracycline, a taxane, and capecitabine
Ixabepilone Common Applications
-
Causes peripheral neuropathies, mainly sensory (20%)
Ixabepilone Special AEs
-
identified from Micromonospora echinospora ssp. calichensis
Calicheamicin γ1I Source
-
Culture of Micromonospora echinospora ssp. calichensis yielded a number of metabolites, the most important being this compound
This compound was an extremely cytotoxic substance that became the lead compound in the emerging novel family of enediynes
Calicheamicin γ1I Chemistry
-
Binds to DNA in the minor groove resulting in: Double-strand breaks, Inhibition of DNA synthesis and function & Cell death
Calicheamicin γ1I MOA
-
This drug is covalently linked to a recombinant humanized monoclonal antibody (Gemtuzumab ozogamicin) directed against the 67 kDa cellsurface glycoprotein CD33
Calicheamicin γ1I
-
Relapsed CD33+ AML in patients in first relapse who are 60 years or older AND who are not considered for cytotoxic chemotherapy
Calicheamicin γ1I Common Applications
-
Infusion-related events: Hypotension and severe allergic reactions
Premedicate with acetaminophen + diphenhydramine (and sometimes methylprednisolone)
Calicheamicin γ1I Special AEs
-
A chemically modified tetracycline: 4-dedimethylamino, 6-demethyl-6-deoxytetracycline
Incyclinide Chemistry
-
Clinical evaluations ongoing in patients with: Kaposi’s sarcoma, Rosacea, Acne & Acute respiratory distress syndrome
Incyclinide Common Applications
-
A plant commonly known as Mayapple or American Mandrake
Podophyllum Source
-
Lignan (dimeric phenylpropanoid)
Biological activity is dependent upon the lactone ring existing in the trans-configuration
Podophyllotoxin Chemistry
-
INHIBIT MICROTUBULE FUNCTION; BINDS TO TUBULIN AND ARRESTS MITOSIS IN METAPHASE - ANTIMITOTIC
Podophyllotoxin MOA
-
Topical therapy of: Anogenital warts due to papillomavirus or condyloma acuminata warts
Podophyllotoxin Common Applications
-
Semi-synthetic lignan derivative of podophyllotoxin
Phosphate ester is useful in high-dose chemotherapy regimens ---- Lessens volume of solution administered & Lessens time of administration
Etoposide Source/Chemistry
-
COMPLEXES WITH TOPOISOMERASE II TO PRODUCE DOUBLE-STRANDED DNA BREAKS; ANTIMITOTIC - G2
Etoposide MOA
-
Refractory testicular tumors (germ cell tumors)
Small cell and non-small cell lung cancer
Hodgkin’s and non-Hodgkin’s lymphomas
Etoposide Common Applications
-
Special AEs not documented ---- Increased risk of secondary malignancies, typically developing within 5-8 years
Etoposide Special AEs
-
Semi-synthetic lignan derivative of podophyllotoxin
Teniposide Source/Chemistry
-
MOA is the same as etoposide
Teniposide MOA
-
Refractory acute leukemia (ALL)
Teniposide Common Application
-
Semi-synthetic lignan derivative of podophyllotoxin that does not have any special adverse effects
Teniposide
-
Source is the fruits of Ammi visnaga Lam.(Apiaceae), a Mediterranean herb
Methoxsalen
-
A furanocoumarin
Pale yellow color
Low water solubility
Methoxsalen Chemistry
-
Noncancer-related applications include:
– Severe idiopathic vitiligo (acquiredleukoderma): Vitiligo
– Enhance tolerance to sunlight in blond persons with fair complexations who suffer “sun allergy” (severe sunburns)
– Severe, recalcitrant, disabling psoriasis
Methoxsalen Common Applications
-
Cancer-related applications include:
–Cutaneous T-cell Lymphoma (CTCL)(Mycosis fungoides)
–Cervical dysplasia: Application of psoralen-containing gel in photodynamic therapy; Limits need for surgical treatment
Methoxsalen Common Applications
-
INTERCALATES WITH DNA FORMING ADDUCTS (WHEN LIGHT ACTIVATED, ACTS AS ALKYLATING AGENT)
Methoxsalen MOA
-
SEVERE BURNS AND BLISTERING IFTHERE IS POST-PUVA LIGHT EXPOSURETOO SOON AFTER THERAPY
Methoxsalen Special AEs
-
Isolated from the Seeds of the plant Euphorbia lathyris (Fam.Euphorbiaceae) or the Sap of the plant Euphorbia peplus (Fam.Euphorbiaceae)
Ingenol Source
-
Diterpene alcohol (4 x C5 units) that is alsoa tetraol
Ingenol Chemistry
-
Activates protein kinase isoforms, inducing apoptosis
Ingenol MOA
-
Applied as a gel in the short-course topical therapy of actinic keratosis and non-melanoma skin cancers – Phase 3
Great benefit in treating actinic keratosis before this lesion progresses to invasive squamous carcinoma
Ingenol Common Applications
-
Physiological metabolite of retinol
Prepared by oxidation of retinal
Tretinoin Source
-
Carotene derivative
Lipophilic, with low water solubility
Tretinoin Chemistry
-
MOA is unknown; Not cytolytic
Induces the maturation of acute promyelocytic leukemia cells in culture
Tretinoin MOA
-
Induction of remission (ONLY) in patients with acute promyelocytic leukemia (APL)(Classification M3 [genetic]) who:
- Are refractory or have relapsed from anthracycline (doxorubicin family) therapy
- Anthracycline-based therapy is contraindicated
Tretinoin Common Application
-
Effects commonly associated with highdoses of Vitamin A (nearly universal): Headache, fever, dryness of skin and mucous membranes
Serious/grave (25-40%): Rapid leukocytosis & Cardiovascular/respiratory multiorgan failure (Retinoic acid-APL Syndrome)
Tretinoin Special AEs
-
A second generation retinoid
Oral capsules useful for the therapy of severe psoriasis in adults
Acitretin (Soriatane)
-
Synthetic
Lipophilic
Weak acid
A “rexinoid”
Bexarotene Source/Chemistry
-
PRECISE MOA - UNKNOWN
SELECTIVELY BINDS AND ACTIVATES RETINOID X RECEPTOR SUBTYPES --- ACTIVATED RECEPTORS FUNCTION AS TRANSCRIPTION FACTORS --- REGULATE GENE EXPRESSION THAT CONTROLS CELL DIFFERENTIATION AND PROLIFERATION
Bexarotene MOA
-
Cutaneous manifestations of Cutaneous Tcell Lymphoma (CTCL) in patients refractory to one or more prior systemic therapies
Bexarotene Common Application
-
Hyperlipidemia
Hypercholesterolemia
Hypothyroidism
Bexarotene Special AEs
-
Light-sensitive polyporphyrin oligomer
Purified product of a hematoporphyrin derivative
Red-orange color
Porfimer Sodium Source/Chemistry
-
Use of a laser light elevates this compound to an excited state which causes radical initiation resulting in ischemic necrosis within a tumor
Porfimer Sodium MOA
-
PhotoDynamic Therapy (PDT) of: Esophageal cancer, Endobronchial non-small cell lung cancer, and Barrett’s Esophagus
Porfimer Sodium Common Applications
-
Many (CV, CNS, GI, Resp. systems)
Porfimer Sodium Special AEs
-
Fermentation product of Streptomyces antibioticus
Pentostatin Source
-
Colorless nucleoside
Weak base
Water soluble
Pentostatin Chemistry
-
TRANSITION STATE INHIBITOR OF ADENOSINE DEAMINASE which results in INHIBITION OF RIBONUCLEOTIDE REDUCTASE
(antimetabolite)
Pentostatin MOA
-
Adult patient therapy
Alpha-interferon-refractory hairy cell leukemia
Pentostatin Common Application
-
Neurologic: Nervousness and insomnia, Depression, Hallucinations
Pentostatin Special AEs
-
Fermentation product of Escherichia coli & Erwinia carotovoras
Enzyme composed of 4 identical subunits
FW = About 136,000 Da
White
Water-soluble
Active at pH 5-9
Asparaginase Source/Chemistry
-
INHIBITS GROWTH OF MALIGNANT CELLS THAT ARE ASPARAGINE-DEPENDENT
Results in INHIBITION OF TUMOR PROTEIN SYNTHESIS
Asparaginase MOA
-
Pediatric acute lymphocytic leukemia (ALL)
Asparaginase Common Application
-
Decreased Vitamin K-dependent clotting factors --> hemorrhage
Hypersensitivity
Asparaginase Special AEs
-
Found in various ores, one of which is orpiment
Obtained as a by-product of smelting copper
White solid
Long known in traditional Chinese medicine as Pi Shuang
Two mineral forms exist: Arsenolite (Commonly occurring form–Octahedral or cubic form) & Claudetite (Thermodynamically stable–Monoclinic form)
Arsenic Trioxide Source/Chemistry
-
Precise MOA not fully elucidated
Induces differentiation of APL cells by degrading PML/RAR-α protein
Induces apoptosis
Inhibits angiogenesis
Arsenic Trioxide MOA
-
Induction of remission and consolidation in acute promyelocytic leukemia (APL)
- Relapsed from or refractory to retinoid and anthracycline chemotherapy
- Whose APL is characterized by the expression of the t(15;17) translocation or PML/RAR-alpha gene expression
Arsenic Trioxide Common Application
-
Prolonged QT interval
APL differentiation syndrome: rash, dyspnea, fluid retention, pleural or pericardial effusions
Leukocytosis
Arsenic Trioxide Special AEs
|
|